Key points are not available for this paper at this time.
Different PD-1 and PD-L1 inhibitors appear to have varying treatment-related adverse events; a comprehensive summary of the incidences of treatment-related adverse events in clinical trials provides an important guide for clinicians.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yucai Wang
Shouhao Zhou
Fang Yang
JAMA Oncology
The University of Texas MD Anderson Cancer Center
Mayo Clinic
University of Tennessee at Knoxville
Building similarity graph...
Analyzing shared references across papers
Loading...
Wang et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d74dbdb54ccf0cfef30ce3 — DOI: https://doi.org/10.1001/jamaoncol.2019.0393